Tobacco nitrosamines as culprits in disease: mechanisms reviewed
- 14 January 2016
- journal article
- review article
- Published by Springer Nature in Journal of Physiology and Biochemistry
- Vol. 72 (1) , 107-120
Abstract
The link between tobacco abuse and cancer is well-established. However, emerging data indicate that toxins in tobacco smoke cause cellular injury due to enhanced toxic/metabolic effects of metabolites, disruption of intracellular signaling mechanisms, and formation of DNA, protein, and lipid adducts that impair function and promote oxidative stress and inflammation. These effects of smoking, which are largely non-carcinogenic, can be produced by tobacco-specific nitrosamines and their metabolites. These factors could account for the increased rates of neurodegeneration and insulin resistance diseases among smokers. Herein, we review nicotine and tobacco-specific nitrosamine metabolism, mechanisms of adduct formation, DNA damage, mutagenesis, and potential mechanisms of disease.Keywords
Funding Information
- National Institutes of Health (AA-11431)
This publication has 101 references indexed in Scilit:
- Urinary levels of the tobacco-specific carcinogen N'-nitrosonornicotine and its glucuronide are strongly associated with esophageal cancer risk in smokersCarcinogenesis, 2011
- Age dependent nicotinic influences over dopamine neuron synaptic plasticityBiochemical Pharmacology, 2009
- MRSI and DTI: a multimodal approach for improved detection of white matter abnormalities in alcohol and nicotine dependenceNMR in Biomedicine, 2009
- Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone‐induced Parkinson's disease modelsJournal of Neuroscience Research, 2008
- Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brainNeuropharmacology, 2003
- Glucuronidation of 4-[(Hydroxymethyl)nitrosamino]-1-(3-pyridyl)-1-butanone, a Metabolically Activated Form of 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone, by Phenobarbital-Treated RatsChemical Research in Toxicology, 1995
- Kinetics and enzyme involvement in the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in microsomes of rat lung and nasal mucosaCarcinogenesis, 1992
- Characterization of insulin-like growth factor I receptors and growth effects in human lung cancer cell linesJournal of Cancer Research and Clinical Oncology, 1992
- Modulation of 4-(methylnitrosamino)-1-(3-pyridyl)-1 butanone demethylation and denitrosation by rat liver microsomesCancer Letters, 1991
- Investigations of metabolic precursors to hemoglobin and DNA adducts of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanoneCarcinogenesis, 1989